These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
239 related articles for article (PubMed ID: 30060056)
1. Histone demethylase KDM2B promotes triple negative breast cancer proliferation by suppressing p15INK4B, p16INK4A, and p57KIP2 transcription. Zheng Q; Fan H; Meng Z; Yuan L; Liu C; Peng Y; Zhao W; Wang L; Li J; Feng J Acta Biochim Biophys Sin (Shanghai); 2018 Sep; 50(9):897-904. PubMed ID: 30060056 [TBL] [Abstract][Full Text] [Related]
2. Depletion of histone demethylase KDM2A inhibited cell proliferation of stem cells from apical papilla by de-repression of p15INK4B and p27Kip1. Gao R; Dong R; Du J; Ma P; Wang S; Fan Z Mol Cell Biochem; 2013 Jul; 379(1-2):115-22. PubMed ID: 23559091 [TBL] [Abstract][Full Text] [Related]
3. Identification of Structural Elements of the Lysine Specific Demethylase 2B CxxC Domain Associated with Replicative Senescence Bypass in Primary Mouse Cells. Deiktakis EE; Abrams M; Tsapara A; Stournaras C; Tsatsanis C; Tsichlis PN; Kampranis SC Protein J; 2020 Jun; 39(3):232-239. PubMed ID: 32270414 [TBL] [Abstract][Full Text] [Related]
4. The H3K36 demethylase Jhdm1b/Kdm2b regulates cell proliferation and senescence through p15(Ink4b). He J; Kallin EM; Tsukada Y; Zhang Y Nat Struct Mol Biol; 2008 Nov; 15(11):1169-75. PubMed ID: 18836456 [TBL] [Abstract][Full Text] [Related]
6. Transcriptional regulation of amino acid metabolism by KDM2B, in the context of ncPRC1.1 and in concert with MYC and ATF4. Chavdoula E; Anastas V; La Ferlita A; Aldana J; Carota G; Spampinato M; Soysal B; Cosentini I; Parashar S; Sircar A; Nigita G; Sehgal L; Freitas MA; Tsichlis PN Metabolism; 2024 Jan; 150():155719. PubMed ID: 37935302 [TBL] [Abstract][Full Text] [Related]
7. Lysine demethylase 2B regulates angiogenesis via Jumonji C dependent suppression of angiogenic transcription factors. Sasaki Y; Higashijima Y; Suehiro JI; Sugasawa T; Oguri-Nakamura E; Fukuhara S; Nagai N; Hirakawa Y; Wada Y; Nangaku M; Kanki Y Biochem Biophys Res Commun; 2022 May; 605():16-23. PubMed ID: 35306360 [TBL] [Abstract][Full Text] [Related]
8. KDM2B is a histone H3K79 demethylase and induces transcriptional repression via sirtuin-1-mediated chromatin silencing. Kang JY; Kim JY; Kim KB; Park JW; Cho H; Hahm JY; Chae YC; Kim D; Kook H; Rhee S; Ha NC; Seo SB FASEB J; 2018 Oct; 32(10):5737-5750. PubMed ID: 29763382 [TBL] [Abstract][Full Text] [Related]
9. Signatures of polycomb repression and reduced H3K4 trimethylation are associated with p15INK4b DNA methylation in AML. Paul TA; Bies J; Small D; Wolff L Blood; 2010 Apr; 115(15):3098-108. PubMed ID: 20190193 [TBL] [Abstract][Full Text] [Related]
10. Interplay between the Epigenetic Enzyme Lysine (K)-Specific Demethylase 2B and Epstein-Barr Virus Infection. Vargas-Ayala RC; Jay A; Manara F; Maroui MA; Hernandez-Vargas H; Diederichs A; Robitaille A; Sirand C; Ceraolo MG; Romero-Medina MC; Cros MP; Cuenin C; Durand G; Le Calvez-Kelm F; Mundo L; Leoncini L; Manet E; Herceg Z; Gruffat H; Accardi R J Virol; 2019 Jul; 93(13):. PubMed ID: 30996097 [TBL] [Abstract][Full Text] [Related]
11. Histone H3K79 demethylation by KDM2B facilitates proper DNA replication through PCNA dissociation from chromatin. Kang JY; Park JW; Hahm JY; Jung H; Seo SB Cell Prolif; 2020 Nov; 53(11):e12920. PubMed ID: 33029857 [TBL] [Abstract][Full Text] [Related]
12. Tip60-dependent acetylation of KDM2B promotes osteosarcoma carcinogenesis. Shi X; Fan M J Cell Mol Med; 2019 Sep; 23(9):6154-6163. PubMed ID: 31218831 [TBL] [Abstract][Full Text] [Related]
13. Aberrant KDM5B expression promotes aggressive breast cancer through MALAT1 overexpression and downregulation of hsa-miR-448. Bamodu OA; Huang WC; Lee WH; Wu A; Wang LS; Hsiao M; Yeh CT; Chao TY BMC Cancer; 2016 Feb; 16():160. PubMed ID: 26917489 [TBL] [Abstract][Full Text] [Related]
14. Lysine-specific demethylase 2B (KDM2B)-let-7-enhancer of zester homolog 2 (EZH2) pathway regulates cell cycle progression and senescence in primary cells. Tzatsos A; Paskaleva P; Lymperi S; Contino G; Stoykova S; Chen Z; Wong KK; Bardeesy N J Biol Chem; 2011 Sep; 286(38):33061-9. PubMed ID: 21757686 [TBL] [Abstract][Full Text] [Related]
15. KDM2B is involved in the epigenetic regulation of TGF-β-induced epithelial-mesenchymal transition in lung and pancreatic cancer cell lines. Wanna-Udom S; Terashima M; Suphakhong K; Ishimura A; Takino T; Suzuki T J Biol Chem; 2021; 296():100213. PubMed ID: 33779563 [TBL] [Abstract][Full Text] [Related]
16. The H3K4me3 histone demethylase Fbxl10 is a regulator of chemokine expression, cellular morphology, and the metabolome of fibroblasts. Janzer A; Stamm K; Becker A; Zimmer A; Buettner R; Kirfel J J Biol Chem; 2012 Sep; 287(37):30984-92. PubMed ID: 22825849 [TBL] [Abstract][Full Text] [Related]
17. Inhibition of microRNA let-7b expression by KDM2B promotes cancer progression by targeting EZH2 in ovarian cancer. Kuang Y; Xu H; Lu F; Meng J; Yi Y; Yang H; Hou H; Wei H; Su S Cancer Sci; 2021 Jan; 112(1):231-242. PubMed ID: 33091189 [TBL] [Abstract][Full Text] [Related]
18. Long noncoding RNA ARHGAP27P1 inhibits gastric cancer cell proliferation and cell cycle progression through epigenetically regulating p15 and p16. Zhang G; Xu Y; Zou C; Tang Y; Lu J; Gong Z; Ma G; Zhang W; Jiang P Aging (Albany NY); 2019 Oct; 11(20):9090-9110. PubMed ID: 31665700 [TBL] [Abstract][Full Text] [Related]
19. Targeting P16INK4A in uterine serous carcinoma through inhibition of histone demethylation. Xiao Z; He Y; Liu C; Xiang L; Yi J; Wang M; Shen T; Shen L; Xue Y; Shi H; Liu P Oncol Rep; 2019 May; 41(5):2667-2678. PubMed ID: 30896884 [TBL] [Abstract][Full Text] [Related]